26198-80-1 Usage
Uses
Used in Pharmaceutical Industry:
1a,1b-dihomoprostaglandin E2 is used as a therapeutic agent for its anti-inflammatory properties, helping to reduce inflammation in various conditions. Its vasodilatory effects also contribute to its potential use in treating cardiovascular diseases by improving blood flow and reducing blood pressure.
Used in Research Applications:
In the field of medical research, 1a,1b-dihomoprostaglandin E2 serves as a valuable tool for studying the mechanisms of inflammation, immune responses, and blood pressure regulation. Its potential role in these processes provides insights into the development of new treatments for related diseases.
Used in Drug Development:
1a,1b-dihomoprostaglandin E2 is utilized in the development of new drugs targeting inflammatory and cardiovascular conditions. Its pharmacological properties make it a promising candidate for the creation of novel therapeutics that can offer improved efficacy and reduced side effects compared to existing treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 26198-80-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,1,9 and 8 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 26198-80:
(7*2)+(6*6)+(5*1)+(4*9)+(3*8)+(2*8)+(1*0)=131
131 % 10 = 1
So 26198-80-1 is a valid CAS Registry Number.
InChI:InChI=1/C22H36O5/c1-2-3-8-11-17(23)14-15-19-18(20(24)16-21(19)25)12-9-6-4-5-7-10-13-22(26)27/h6,9,14-15,17-19,21,23,25H,2-5,7-8,10-13,16H2,1H3,(H,26,27)/b9-6-,15-14+/t17-,18?,19+,21+/m0/s1
26198-80-1Relevant academic research and scientific papers
Stereoselective preparation of key intermediates for the synthesis of iso-, neuro- and phyto-prostane family members: Inaugural asymmetric synthesis of 17-E2c-dihomo- and 17-F2c-dihomo-isoprostanes
Gandini, Andrea,Amin, Ahmed A.,Amin, Hawraz Ibrahim M.,Corriero, Davide,Porta, Alessio,Zanoni, Giuseppe
, p. 2393 - 2396 (2018/04/12)
A practical methodology for the synthesis of key intermediates for isoprostane, neuroprostane and dihomo-isoprostane preparation has been described. The key strategy involved a three stage C-12 stereocenter inversion of the configuration of a Corey lacton
